Suresh Ponnayyan Sulochana - Catalysis

Author Information

Dr. Suresh Ponnayyan Sulochana is a researcher affiliated with the Supramolecular and Catalysis Lab, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, Tamil Nadu, India. His work primarily focuses on pharmacokinetics, bioanalytical methods, and the discovery and optimization of compounds with potential therapeutic applications.

Research Contributions

Dr. Suresh Ponnayyan Sulochana has made significant contributions to the field of pharmacokinetics and bioanalytical chemistry. His research spans the identification and optimization of novel compounds, such as Aurora kinase inhibitors and cannabinoid type 2 receptor-selective compounds. He has also explored pharmacokinetics in various biological systems, including studies on the disposition of therapeutic compounds in mice and rabbits. His work includes the development of validated methods for the simultaneous quantitation of various drugs in plasma, which are crucial for pharmacokinetic studies and the advancement of cancer therapy.

Aliases

S. Sulochana, Suresh P. Sulochana, Suresh Ponnayyan Sulochana, Suresh P Sulochana

Publication and Citation Metrics

Metric	Value
Citation Count	160
h-index	7
Paper Count	34

Publications:

Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor

DOI: 10.3390/molecules27020509

Year: 2022

HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone’s Psychomotor Effects in Female Mice

DOI: 10.3390/v13050813

Year: 2021

Pharmacokinetics of Darolutamide in Mouse - Assessment of the Disposition of the Diastereomers, Key Active Metabolite and Interconversion Phenomenon: Implications to Cancer Patients.

DOI: 10.2174/1872312814666200521091236

Year: 2020

Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors.

DOI: 10.1016/j.bioorg.2020.103800

Year: 2020

Validated LC-MS/MS Method for Simultaneous Quantitation of SAFit-1 and SAFit-2 in Mice Plasma: Application to a Pharmacokinetic Study.

DOI: 10.1055/a-1164-6123

Year: 2020

A concise review of bioanalytical methods of small molecule immuno-oncology drugs in cancer therapy.

DOI: 10.1002/bmc.4996

Year: 2020

Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime

DOI: 10.1080/00498254.2019.1624872

Year: 2019

Simultaneous determination of bendamustine and γ-hydroxybendamustine in mice dried blood spots and its application in a mice pharmacokinetic study.

DOI: 10.1016/j.jpba.2019.05.052

Year: 2019

Validated LC-ESI-MS/MS method for the determination of tunicamycin in rat plasma: Application to a pharmacokinetic study.

DOI: 10.1002/bmc.4661

Year: 2019

Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mice plasma: Application to a pharmacokinetic study.

DOI: 10.1002/bmc.4658

Year: 2019

How to Apply for Institutional Membership?

What is the Role of Judgment in Catalyst Selection?

How to Implement Blockchain in Catalytic Supply Chains?

What are the Environmental Benefits of Catalysis in Fuel Production?

How do RTDs affect reactor design?

What Are the Maintenance and Operational Costs?

How to Provide Constructive Feedback in Catalysis?

What is Operational Load in Catalysis?

What are Magnetic Bearings?

How Long Do These Programs Typically Last?

Partnered Content Networks

Relevant Topics